Lingxiang Zhu Selected Research

Pharmaceutical Preparations

1/2015	A locked nucleic acid (LNA)-based real-time PCR assay for the rapid detection of multiple bacterial antibiotic resistance genes directly from positive blood culture.
1/2013	Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingxiang Zhu Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
3	Inflammation (Inflammations) 01/2020 - 01/2016
3	Asthma (Bronchial Asthma) 01/2020 - 07/2011
3	Infections 01/2016 - 05/2012
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2015
2	Virus Diseases (Viral Diseases) 06/2014 - 01/2014
1	Human Influenza (Influenza) 05/2022
1	COVID-19 12/2020
1	Hemiplegia (Spastic Hemiplegia) 04/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2020
1	Autistic Disorder (Autism) 04/2020
1	Cerebral Palsy (Spastic Diplegia) 04/2020
1	Quadriplegia (Spastic Quadriplegia) 04/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2020
1	Allergic Rhinitis 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Aneuploidy (Aneuploid) 03/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2015
1	Bacterial Infections (Bacterial Infection) 01/2013
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2012
1	Occupational Diseases (Occupational Disease) 07/2011
1	Chronic Bronchitis 07/2011
1	Leukemia 07/2011
1	Airway Remodeling 05/2009
1	Disease Progression 05/2009

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2020 - 06/2014
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2013
2	Antiviral Agents (Antivirals)IBA 06/2014 - 05/2009
2	MucinsIBA 01/2012 - 07/2011
1	RTKI cpdIBA 05/2022
1	Circulating Tumor DNAIBA 01/2021
1	Nucleic AcidsIBA 12/2020
1	Mitochondrial DNA (mtDNA)IBA 04/2020
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Biological ProductsIBA 01/2020
1	ArsenicIBA 01/2020
1	ParaffinIBA 01/2020
1	PAR-2 ReceptorIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	AllergensIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	locked nucleic acidIBA 03/2019
1	human SCGB1A1 proteinIBA 01/2019
1	OvalbuminIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	UteroglobinIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	SmokeIBA 01/2015
1	ChemokinesIBA 01/2014
1	Staphylococcal Protein A (Protein A)IBA 01/2014
1	Double-Stranded RNA (RNA, Double Stranded)IBA 05/2012
1	VanadiumIBA 07/2011
1	vanadium pentoxideIBA 07/2011

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2020